T. Rowe Price Associates’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $42M | Sell |
|
|||||
|
2020
Q4 | $42.8M | Sell |
|
|||||
|
2020
Q3 | $24M | Buy |
|
|||||
|
2020
Q2 | $23.6M | Sell |
|
|||||
|
2020
Q1 | $19.2M | Sell |
|
|||||
|
2019
Q4 | $42M | Sell |
|
|||||
|
2019
Q3 | $44.5M | Sell |
|
|||||
|
2019
Q2 | $48.3M | Sell |
|
|||||
|
2019
Q1 | $40.2M | Sell |
|
|||||
|
2018
Q4 | $45.1M | Buy |
|
|||||
|
2018
Q3 | $55.1M | Buy |
|
|||||
|
2018
Q2 | $54.9M | Buy |
|
|||||
|
2018
Q1 | $49M | Buy |
|
|||||
|
2017
Q4 | $42.4M | Buy |
|
|||||
|
2017
Q3 | $37.9M | Buy |
|
|||||
|
2017
Q2 | $29.9M | Buy |
|
|||||
|
2017
Q1 | $29.5M | Buy |
|
|||||
|
2016
Q4 | $25.7M | Buy |
|
|||||
|
2016
Q3 | $24M | Buy |
|
|||||
|
2016
Q2 | $19M | Buy |
|
|||||
|
2016
Q1 | $18.4M | Buy |
|
|||||
|
2015
Q4 | $13.8M | Buy |
|
|||||
|
2015
Q3 | $544K | Hold |
|
|||||
|
2015
Q2 | $515K | Hold |
|
|||||
|
2015
Q1 | $456K | Buy |
|
|||||
|
2014
Q4 | $277K | Sell |
|
|||||
|
2014
Q3 | $272K | Hold |
|
|||||
|
2014
Q2 | $289K | Hold |
|
|||||
|
2014
Q1 | $266K | Buy |
|
|||||
|
2013
Q4 | $254K | Hold |
|
|||||
|
2013
Q3 | $239K | Buy |
|